Publications

  1. Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination. Hum Genet. 2014 Nov; 133(11):1407-17. Epub 2014 Aug 07.
    View PubMed
  2. Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankratz VS, Poland GA. Polymorphisms in HLA-DPB1 Are Associated With Differences in Rubella Virus-Specific Humoral Immunity After Vaccination. J Infect Dis. 2014 Oct 06.
    View PubMed
  3. Ovsyannikova IG, Pankratz VS, Salk HM, Kennedy RB, Poland GA. HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study. Hum Genet. 2014 Sep; 133(9):1083-92. Epub 2014 Jun 01.
    View PubMed
  4. Poland GA, Ovsyannikova IG, Kennedy RB, Lambert ND, Kirkland JL. A systems biology approach to the effect of aging, immunosenescence and vaccine response. Curr Opin Immunol. 2014 Aug; 29:62-8. Epub 2014 May 13.
    View PubMed
  5. Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients. Immunogenetics. 2014 Aug; 66(7-8):493-9. Epub 2014 May 09.
    View PubMed
  6. Kennedy RB, Ovsyannikova IG, Lambert ND, Haralambieva IH, Poland GA. The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines. 2014 May; 13(5):657-69. Epub 2014 Apr 04.
    View PubMed
  7. Haralambieva IH, Salk HM, Lambert ND, Ovsyannikova IG, Kennedy RB, Warner ND, Pankratz VS, Poland GA. Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts. Vaccine. 2014 Apr 7; 32(17):1946-53. Epub 2014 Feb 13.
    View PubMed
  8. Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, Poland GA. Associations between Single Nucleotide Polymorphisms in Cellular Viral Receptors and Attachment Factor-Related Genes and Humoral Immunity to Rubella Vaccination. PLoS One. 2014; 9(6):e99997. Epub 2014 Jun 19.
    View PubMed
  9. Simon WL, Salk HM, Ovsyannikova IG, Kennedy RB, Poland GA. Cytokine production associated with smallpox vaccine responses. Immunotherapy. 2014; 6(10):1097-112.
    View PubMed
  10. Ovsyannikova IG, Haralambieva IH, Kennedy RB, O'Byrne MM, Pankratz VS, Poland GA. Genetic variation in IL18R1 and IL18 genes and Inteferon gamma ELISPOT response to smallpox vaccination: an unexpected relationship. J Infect Dis. 2013 Nov 1; 208(9):1422-30. Epub 2013 Jul 30.
    View PubMed
  11. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA. Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals. Hum Immunol. 2013 Oct; 74(10):1263-6. Epub 2013 Jun 24.
    View PubMed
  12. Kennedy RB, Oberg AL, Ovsyannikova IG, Haralambieva IH, Grill D, Poland GA. Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes Immun. 2013 Jul-Aug; 14(5):277-85. Epub 2013 Apr 18.
    View PubMed
  13. Poland GA, Kennedy RB, McKinney BA, Ovsyannikova IG, Lambert ND, Jacobson RM, Oberg AL. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin Immunol. 2013 Apr; 25(2):89-103. Epub 2013 Jun 05.
    View PubMed
  14. Haralambieva IH, Ovsyannikova IG, Pankratz VS, Kennedy RB, Jacobson RM, Poland GA. The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches. Expert Rev Vaccines. 2013 Jan; 12(1):57-70.
    View PubMed
  15. McKinney BA, White BC, Grill DE, Li PW, Kennedy RB, Poland GA, Oberg AL. ReliefSeq: a gene-wise adaptive-K nearest-neighbor feature selection tool for finding gene-gene interactions and main effects in mRNA-Seq gene expression data. PLoS One. 2013; 8(12):e81527. Epub 2013 Dec 10.
    View PubMed
  16. Haralambieva IH, Oberg AL, Ovsyannikova IG, Kennedy RB, Grill DE, Middha S, Bot BM, Wang VW, Smith DI, Jacobson RM, Poland GA. Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS One. 2013; 8(5):e62149. Epub 2013 May 01.
    View PubMed
  17. Fridley BL, Jenkins GD, Grill DE, Kennedy RB, Poland GA, Oberg AL. Soft truncation thresholding for gene set analysis of RNA-seq data: application to a vaccine study. Sci Rep. 2013; 3:2898. Epub 2013 Oct 09.
    View PubMed
  18. Ovsyannikova IG, Haralambieva IH, Kennedy RB, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination. Gene. 2012 Nov 15; 510(1):59-65. Epub 2012 Aug 23.
    View PubMed
  19. Haralambieva IH, Oberg AL, Dhiman N, Ovsyannikova IG, Kennedy RB, Grill DE, Jacobson RM, Poland GA. High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination. J Infect Dis. 2012 Nov 15; 206(10):1512-20. Epub 2012 Sep 04.
    View PubMed
  20. Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Poland GA. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet. 2012 Sep; 131(9):1403-21. Epub 2012 May 19.
    View PubMed
  21. Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Jacobson RM, Poland GA. Genome-wide genetic associations with IFNgamma response to smallpox vaccine. Hum Genet. 2012 Sep; 131(9):1433-51. Epub 2012 Jun 03.
    View PubMed
  22. Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB J. 2012 Jul; 26(7):2911-8. Epub 2012 Apr 06.
    View PubMed
  23. Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine. 2012 Jun 13; 30(28):4182-9. Epub 2012 Apr 25.
    View PubMed
  24. Kennedy RB, Ovsyannikova IG, Haralambieva IH, O'Byrne MM, Jacobson RM, Pankratz VS, Poland GA. Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine. 2012 Mar 9; 30(12):2159-67. Epub 2012 Jan 20.
    View PubMed
  25. Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, Poland GA. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination. Viral Immunol. 2012 Feb; 25(1):29-36. Epub 2012 Jan 12.
    View PubMed
  26. Poland GA, Kennedy RB, Ovsyannikova IG. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? PLoS Pathog. 2011 Dec; 7(12):e1002344. Epub 2011 Dec 29.
    View PubMed
  27. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine. 2011 Oct 19; 29(45):7883-95. Epub 2011 Aug 27.
    View PubMed
  28. Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunol. 2011 Oct; 24(5):415-20. Epub 2011 Sep 29.
    View PubMed
  29. Poland GA, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Jacobson RM. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS. 2011 Sep; 15(9):625-36. Epub 2011 Jul 06.
    View PubMed
  30. Kennedy RB, Poland GA. The top five "game changers" in vaccinology: toward rational and directed vaccine development. OMICS. 2011 Sep; 15(9):533-7. Epub 2011 Aug 04.
    View PubMed
  31. Haralambieva IH, Ovsyannikova IG, Dhiman N, Kennedy RB, O'Byrne M, Pankratz VS, Jacobson RM, Poland GA. Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans. J Infect Dis. 2011 Aug 1; 204(3):433-41.
    View PubMed
  32. Oberg AL, Kennedy RB, Li P, Ovsyannikova IG, Poland GA. Systems biology approaches to new vaccine development. Curr Opin Immunol. 2011 Jun; 23(3):436-43. Epub 2011 May 11.
    View PubMed
  33. Oberg AL, Dhiman N, Grill DE, Ryan JE, Kennedy RB, Poland GA. Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman(R) low density immune arrays. J Immunol Methods. 2011 Mar 7; 366(1-2):69-78. Epub 2011 Jan 28.
    View PubMed
  34. Kennedy RB, Poland GA. The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins. Virology. 2010 Dec 20; 408(2):232-40. Epub 2010 Oct 18.
    View PubMed
  35. Dhiman N, Haralambieva IH, Kennedy RB, Vierkant RA, O'Byrne MM, Ovsyannikova IG, Jacobson RM, Poland GA. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics. 2010 Apr; 62(4):197-210. Epub 2010 Mar 10.
    View PubMed
  36. Kennedy RB, Ovsyannikova IG, Vierkant RA, Jacobson RM, Poland GA. Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses. Hum Immunol. 2010 Feb; 71(2):128-35. Epub 2009 Nov 05.
    View PubMed
  37. Tosh PK, Kennedy RB, Vierkant RA, Jacobson RM, Poland GA. Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity. Viral Immunol. 2009 Dec; 22(6):451-6.
    View PubMed
  38. Kennedy RB, Ovsyannikova I, Poland GA. Smallpox vaccines for biodefense. Vaccine. 2009 Nov 5; 27 Suppl 4:D73-9.
    View PubMed
  39. Kennedy R, Pankratz VS, Swanson E, Watson D, Golding H, Poland GA. Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay. Clin Vaccine Immunol. 2009 Aug; 16(8):1105-12. Epub 2009 Jun 17.
    View PubMed
  40. Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA. The immunology of smallpox vaccines. Curr Opin Immunol. 2009 Jun; 21(3):314-20. Epub 2009 Jun 11.
    View PubMed
  41. Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA, Poland GA. Gender effects on humoral immune responses to smallpox vaccine. Vaccine. 2009 May 26; 27(25-26):3319-23. Epub 2009 Feb 05.
    View PubMed
  42. Kennedy R, Celis E. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev. 2008 Apr; 222:129-44.
    View PubMed
  43. Kennedy R, Poland GA. T-Cell epitope discovery for variola and vaccinia viruses. Rev Med Virol. 2007 Mar-Apr; 17(2):93-113.
    View PubMed
  44. Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, Poland GA, Jacobson RM. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis. 2007 Jan 1; 195(1):21-9. Epub 2006 Nov 20.
    View PubMed
  45. Kennedy R, Celis E. T helper lymphocytes rescue CTL from activation-induced cell death. J Immunol. 2006 Sep 1; 177(5):2862-72.
    View PubMed
  46. Kennedy R, Undale AH, Kieper WC, Block MS, Pease LR, Celis E. Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responses. J Immunol. 2005 Apr 1; 174(7):3967-77.
    View PubMed
  47. Davila E, Kennedy R, Celis E. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade. Cancer Res. 2003 Jun 15; 63(12):3281-8.
    View PubMed
  48. Lu J, Giuntoli RL 2nd, Omiya R, Kobayashi H, Kennedy R, Celis E. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Clin Cancer Res. 2002 Dec; 8(12):3877-84.
    View PubMed
  49. Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer Res. 2002 Oct 1; 62(19):5495-504.
    View PubMed
  50. Giuntoli RL, Lu J, Kobayashi H, Kennedy R, Celis E. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin Cancer Res. 2002 Mar; 8(3):922-31.
    View PubMed
  51. Kobayashi H, Kennedy R, Lu J, Davila E, Celis E. MHC-binding peptides as immunotherapeutics for cancer. Immunol Invest. 2000 May; 29(2):105-10.
    View PubMed
  52. Borson ND, Strausbauch MA, Kennedy RB, Oda RP, Landers JP, Wettstein PJ. Temporal sequence of transcription of perforin, Fas ligand, and tumor necrosis factor-alpha genes in rejecting skin allografts. Transplantation. 1999 Mar 15; 67(5):672-80.
    View PubMed